Heterogeneity in resistance mechanisms causes shorter duration of epidermal growth factor receptor kinase inhibitor treatment in lung cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Tetsuya Mitsudomi Kenichi Suda |
| Publication date | November 25, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |